BioSpace News Archive

As 2018 comes to a close, analysts, journalists, investors and industry-watchers are studying their crystal balls to see what trends to watch in the upcoming year. Here are 7 trends most likely to be hitting the news cycle.

Gossamer Bio, headquartered in San Diego, announced plans for its initial public offering (IPO) just before Christmas.

In a December 17, Washington Post op-ed, Senator Elizabeth Warren (D-MA), proposed The Affordable Drug Manufacturing Act, which would allow the Department of Health and Human Services (HHS) to manufacture or contract out the manufacture of generic drugs.

Bavarian Nordic A/S today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for the liquid-frozen version of the MVA-BN®for active immunization against smallpox in adults age 18 years and older.

After a delay in review, the FDA approved Acorda’s Inbrija for the intermittent treatment of OFF episodes of Parkinson’s.

The battle of the bulge is ongoing and it appears that Americans are losing, according to a report from the U.S. Centers for Disease Control and Prevention. The report shows that Americans are losing height and gaining girth.

Alexion Pharmaceuticals and Stemline Therapeutics both secured FDA approval for their drugs.

Galapagos NV will participate in the 37th Annual J.P. Morgan Healthcare Conference on January 8 & 9, 2019.

Professor Robert K. Ernst, PhD, of the University of Maryland School of Dentistry (UMSOD) has been awarded a five-year, $6.4 million contract from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) to develop and test new adjuvants for use in future vaccines. An adjuvant is added to a vaccine to, as NIAID notes, “enhance its ability to induce protection against infection.”

Capricor Therapeutics has placed a voluntary hold on its Phase II clinical trial for a Duchene Muscular Dystrophy treatment on hold after a patient experienced a severe allergic reaction during dosing.